Person in an online medical appointment from home

Cerebral had a difficult few years. Here's what that means for you in 2026.

Online therapy and medication management, with insurance. The platform restructured significantly after regulatory scrutiny in 2022. The current model is more limited — and more defensible.

34+ Platforms ReviewedExpert-WrittenUpdated MonthlyNo Sponsored Rankings

Cerebral at a Glance

Pricing & Plans

Cerebral charges a monthly subscription for its services. Medication management alone starts around $99/month. A combined therapy and medication management plan runs approximately $325/month. Several insurance plans are accepted — Aetna, Cigna, and others — which can significantly reduce your out-of-pocket cost depending on your benefits. The medication cost itself is separate from the subscription and billed through your pharmacy. Confirm your specific carrier's coverage before signing up, as in-network status varies by plan and state.

$99
per month starting (medication management)

Knowing a platform's history isn't grounds for automatic disqualification — but it is grounds for going in with clear expectations about what you're choosing and why. Cerebral's narrower current scope is both a consequence of what happened and a reason to feel more comfortable with it for the right use case.

What Works Now

Insurance acceptance — a real cost advantage
For the right insurance plan, Cerebral's combined therapy and medication plan becomes significantly more affordable. Out-of-pocket combined therapy and psychiatry can run $500–700/month; insurance coverage changes that math considerably. Confirm your specific coverage before assuming it applies.
Therapy and medication in one place
The structural advantage of combined care still applies — your prescriber and your therapist are on the same platform with visibility into your overall treatment. For depression and anxiety specifically, where medication and therapy often work better together, having them coordinated rather than siloed has clinical value.
Restructured clinical protocols post-2022
The prescribing standards that caused the original problems have been revised. Cerebral now focuses on non-controlled medications, has tightened its clinical review processes, and operates under closer oversight. The post-restructure model is more conservative — which is appropriate.

Where It Falls Short

The regulatory history is real and worth knowing
The DEA investigation, the FTC settlement, the stimulant prescribing controversy — these happened, they were serious, and they're worth knowing about before you decide to use Cerebral. We're not suggesting the current platform has the same problems. We are suggesting you should be an informed consumer. Read about what happened, evaluate the post-restructure model yourself, and make the decision with full context.
No stimulant prescribing for ADHD
Cerebral stopped prescribing stimulants and has not fully restored that capability. If you have ADHD and need stimulant medication management, Cerebral is not the right platform. Klarity or Talkiatry are more appropriate options for that use case.
Better alternatives exist if your insurance covers them
If your insurance covers Talkspace (which offers both therapy and psychiatry in-network), or if you can access in-network psychiatry through Talkiatry alongside an in-network therapist through Headway, those combinations are preferable without the reputational baggage. Cerebral's value case is strongest where alternatives aren't accessible.
Cancellation experience has been a consistent user complaint
The FTC settlement was partly related to cancellation practices. Cerebral has since changed its cancellation process, but user reviews still surface friction here more often than with comparable platforms. Document your cancellation in writing if and when you decide to stop.

Who Cerebral Is Best For (Now)

People managing depression or anxiety who need both therapy and medication
The combined plan for non-controlled medication management — antidepressants, anti-anxiety medications — is Cerebral's defensible lane in 2026. For this specific use case with insurance that covers the platform, it functions reasonably.
Insured clients who've confirmed coverage and understand the history
If your insurance covers Cerebral and you're using it for depression or anxiety medication management — not ADHD stimulants — and you've made that decision with full context, it's a usable option. Informed use is the operative phrase.

Who Should Look Elsewhere

Anyone needing ADHD stimulant medication
Klarity or Talkiatry are better options for ADHD medication management. Cerebral no longer has a reliable stimulant prescribing pathway.
People who prefer not to use a platform with this history
That's a completely reasonable position. Brightside offers combined therapy and medication for depression and anxiety without the same history. Talkspace offers integrated psychiatry with insurance. Either is a clean alternative.

How Cerebral Compares

CerebralBrightsideTalkspace
Price$99–325/mo$95–349/mo$69–109/wk or copay
InsuranceYes — several plansNoYes — Aetna, BCBS, Cigna, UHC
Therapy + MedicationYesYesYes
ADHD stimulantsNo (stopped 2022)NoLimited
Depression/anxiety medsYesYesYes
Regulatory historyDEA + FTC issues 2022CleanClean
Rating3.7/54.2/5 Recommended4.3/5 Recommended

Our Verdict

Cerebral is not the platform it was in 2021, for better and for worse. The worst excesses of the telehealth boom — loose stimulant prescribing, growth-over-care incentives — got addressed through regulation and restructuring. What's left is a more limited platform: combined therapy and non-controlled medication management, with insurance accepted. If that's what you need, it works. If you need ADHD stimulant management, or you'd rather not use a platform with this history, there are clean alternatives. We've listed them. Go in informed either way.

Affiliate link — we may earn a commission if you sign up, at no extra cost to you.

Coming Soon — Check Back

About Our Editorial Process

DTS

DTS Research Team Editorial

Medication Management · Regulatory Context · Platform Research

Every recommendation on this page was independently researched, cross-referenced against current clinical literature, and verified for accuracy by the DTS editorial team. Platforms are re-evaluated monthly.

Read our editorial process →

We're not therapists — we're researchers who spent hundreds of hours comparing these platforms so you don't have to. Some links on this page are affiliate links, meaning we may earn a commission if you sign up. This never influences which platforms we recommend or how honestly we report their limitations.

Pricing reflects our most recent research as of March 2026 and may vary by location and insurance plan. Confirm current pricing and insurance coverage directly with Cerebral before signing up. Regulatory history is based on publicly reported events as of our review date.